English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Jenburph Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Jenburkt Pharmaceuticals

    Small Cap
    ₹872.4
    +7.2 (0.83%)
    29 June, 2024 02:53 BSE: 524731 NSE: JENBURPHISIN: INE354A01013

    Start SIP in Jenburkt Pharmaceuticals

    Start SIP

    Jenburkt Pharmaceuticals Performance

    Day Range

    • Low 0
    • High 0
    ₹ 872

    52 Week Range

    • Low 0
    • High 0
    ₹ 872
    • Open Price0
    • Previous Close0
    • Volume

    Jenburkt Pharmaceuticals Share Price

    • Over 1 Month +8.87%
    • Over 3 Month +24.81%
    • Over 6 Month +28.63%
    • Over 1 Year +21.8%

    Jenburkt Pharmaceuticals Key Statistics

    Jenburkt Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3936382935
    Operating Expenses Qtr Cr 2928292228
    Operating Profit Qtr Cr 107977
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 00000
    Tax Qtr Cr 22222
    Net Profit Qtr Cr 85756
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 147142
    Operating Expenses Annual Cr 109106
    Operating Profit Annual in Cr 3330
    Depreciation Cr 22
    Interest Annual Cr 00
    Tax Annual Cr 98
    Net Profit Annual Cr 2625
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 8
    Cash from Investing Activity Annual Cr -1
    Cash from Financing Annual Activity Cr -7
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 145122
    Fixed Assets Annual Cr 1211
    Total Non Current Assets Annual Cr 5561
    Total Current Assets Annual Cr 11081
    Total Assets Annual Cr 165142
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 328277
    ROE Annual % 1820
    ROCE Annual % 2426
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2726
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Jenburkt Pharmaceuticals

    Jenburkt Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹872.4
    +7.2 (0.83%)
    pointer
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹849.41
    • 50 Day
    • ₹818.22
    • 100 Day
    • ₹791.12
    • 200 Day
    • ₹759.37
    • 20 Day
    • ₹843.12
    • 50 Day
    • ₹809.58
    • 100 Day
    • ₹783.02
    • 200 Day
    • ₹743.10

    Jenburkt Pharmaceuticals Resistance and Support

    PIVOT
    ₹867.64
    Resistance
    First Resistance 890.27
    Second Resistance 908.13
    Third Resistance 930.77
    RSI 57.84
    MFI 37.51
    MACD Single Line 18.44
    MACD 20.27
    Support
    First Support 849.77
    Second Support 827.13
    Third Supoort 809.27

    Jenburkt Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,749 114,594 65.52
    Week 2,339 189,319 80.94
    1 Month 4,668 367,820 78.8
    6 Month 3,504 272,679 77.82

    Jenburkt Pharmaceuticals Result Highlights

    Jenburkt Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Jenburkt Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-28 Audited Results & Dividend
    2024-02-06 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-23 Audited Results, Dividend & A.G.M.

    Jenburkt Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Jenburkt Pharmaceuticals FAQs

    What is Share Price of Jenburkt Pharmaceuticals ?

    Jenburkt Pharmaceuticals share price is ₹872 As on 29 June, 2024 | 02:39

    What is the Market Cap of Jenburkt Pharmaceuticals ?

    The Market Cap of Jenburkt Pharmaceuticals is ₹385 Cr As on 29 June, 2024 | 02:39

    What is the P/E ratio of Jenburkt Pharmaceuticals ?

    The P/E ratio of Jenburkt Pharmaceuticals is 14.8 As on 29 June, 2024 | 02:39

    What is the PB ratio of Jenburkt Pharmaceuticals ?

    The PB ratio of Jenburkt Pharmaceuticals is 2.7 As on 29 June, 2024 | 02:39

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.